An Open Labelled Randomised Controlled Clinical Study to evaluate the efficacy of Ksheerbala Tail Nasya and Ashwagandha Tail Nasya in the management of cervical spondylosis - NI

Institute for Ayurved Studies & Research0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年6月24日

试验速览

暂无简介。

•1 Patients willing to sign the consent form.
•2 Patients aged between 25 and 55 yrs of either sex.
•3 Patients having signs and symptoms of cervical spondylosis exceeding not more than 3 years with or without radiological changes.
•4 Patients fit for Nasya Karma.

•1 Patients having age below 25 and above 55 yrs of either sex.
•2 Patients with chronicity of more than 3 years.
•3 Patients unfit for Nasya karma.
•4 Patients not willing for the Nasya karma.
•5 Patients diagnosed with Myelopathy or stenosis of Spinal Canal, and other related conditions like Ankylosing spondylitis.
•6 Patient diagnosed with Tuberculosis of spine, spinal tumors, Vascular lesions, Neoplasms, history of trauma, fractures and surgical history.
•7 Patients having any other systemic disorders like cardiac disease, renal diseases and hypertension or endocrinal disorders.
•8 Pregnant or lactating mothers.

发起方

Institute for Ayurved Studies & Research